Brief Title
Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
Official Title
Observational Study of Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
Brief Summary
To study the association between aristolochic acid and urothelial carcinoma in Taiwan
Study Type
Observational
Primary Outcome
the incidence of aristolochic-acid DNA adduct in the samples
Condition
Urothelial Carcinoma
Study Arms / Comparison Groups
Urothelial carcinoma
Description: The DNA samples extracted from the urothelial carcinoma tissue
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
100
Start Date
March 2009
Completion Date
March 2012
Eligibility Criteria
Inclusion Criteria: - the resected kidney tissue in the tissue bank Exclusion Criteria: - the patients who had been ever exposed to arsenics, rubber, chemicals, irradiation for pelvis, or received chemotherapy.
Gender
All
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
, 886-2-23123456, [email protected]
Location Countries
Taiwan
Location Countries
Taiwan
Administrative Informations
NCT ID
NCT00867633
Organization ID
200804011R
Responsible Party
Principal Investigator
Study Sponsor
National Taiwan University Hospital
Study Sponsor
, ,
Verification Date
February 2012